Reduced expression of the MDA5 Gene IFIH1 prevents autoimmune diabetes

Diabetes

Volumn 64, Issue 6, 2015, Pages 2184-2193

  Lincez, Pamela J ^a   Shanina, Iryna ^a   Horwitz, Marc S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON INDUCED WITH HELICASE C DOMAIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; PEPTIDES AND PROTEINS; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DEAD BOX PROTEIN; IFIH1 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; FEMALE; GENE LOCUS; GENETIC RISK; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREATIC LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; ANIMAL; FLOW CYTOMETRY; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; DEAD-BOX RNA HELICASES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; MALE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84981534746     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1223     Document Type: Article

References (25)

1. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986;314:1360-1368.
2. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009;324:387-389.
3. Downes K, Pekalski M, Angus KL, et al. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS ONE 2010;5:e12646.
4. Smyth DJ, Cooper JD, Bailey R, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006;38:617-619.
5. Ferreira RC, Guo H, Coulson RM, et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes 2014;63:2538-2550.
6. Dotta F, Sebastiani G. Enteroviral infections and development of type 1 diabetes: The Brothers Karamazov within the CVBs. Diabetes 2014;63:384- 386.
7. Richardson SJ, Horwitz MS. Is type 1 diabetes "going viral"? Diabetes 2014;63:2203-2205.
8. Reikine S, Nguyen JB, Modis Y. Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5. Front Immunol 2014;5:342.
9. Funabiki M, Kato H, Miyachi Y, et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 2014;40:199-212.
10. McCartney SA, Vermi W, Lonardi S, et al. RNA sensor-induced type I IFN prevents diabetes caused by a β cell- Tropic virus in mice. J Clin Invest 2011;121: 1497-1507.
11. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998;4:781-785.
12. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000;49:708-711.
13. Kondrashova A, Hyöty H. Role of viruses and other microbes in the pathogenesis of type 1 diabetes. Int Rev Immunol 2014;33:284-295.
14. Schmittgen TD, Livak KJ. Analyzing real- Time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-1108.
15. González-Navajas JM, Lee J, David M, Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012;12:125-135.
16. Guerder S, Joncker N, Mahiddine K, Serre L. Dendritic cells in tolerance and autoimmune diabetes. Curr Opin Immunol 2013;25:670-675.
17. Jeker LT, Bour-Jordan H, Bluestone JA. Breakdown in peripheral tolerance in type 1 diabetes in mice and humans. Cold Spring Harb Perspect Med 2012;2: A007807.
18. Rowland SL, Riggs JM, Gilfillan S, et al. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J Exp Med 2014;211:1977-1991.
19. Dotta F, Censini S, van Halteren AG, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007;104:5115-5120.
20. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta- Analysis of observational molecular studies. BMJ 2011;342:d35.
21. Xia CQ, Peng R, Chernatynskaya AV, et al. Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production. J Immunol 2014;193: 1024-1034.
22. Marek-Trzonkowska N, Mysliwiec M, Dobyszuk A, et al. Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up. Clin Immunol 2014;153:23-30.
23. Bluestone JA, Tang Q. Therapeutic vaccination using CD4+CD25+ antigenspecific regulatory T cells. Proc Natl Acad Sci USA 2004;101(Suppl. 2):14622-14626.
24. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004;199:1455-1465.
25. Smilek DE, Ehlers MR, Nepom GT. Restoring the balance: immunotherapeutic combinations for autoimmune disease. Dis Model Mech 2014;7:503-513.